T. Rowe Price Investment Management Inc. Sells 4,184 Shares of Agilent Technologies, Inc. $A

T. Rowe Price Investment Management Inc. cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.1% during the 4th quarter, Holdings Channel reports. The firm owned 8,143,863 shares of the medical research company’s stock after selling 4,184 shares during the quarter. T. Rowe Price Investment Management Inc.’s holdings in Agilent Technologies were worth $1,108,136,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Bridgefront Capital LLC purchased a new stake in Agilent Technologies during the third quarter worth about $1,323,000. Wellington Management Group LLP boosted its stake in Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after acquiring an additional 433,342 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after acquiring an additional 24,687 shares during the last quarter. Generation Investment Management LLP grew its position in shares of Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after acquiring an additional 582,093 shares during the period. Finally, Champlain Investment Partners LLC increased its stake in shares of Agilent Technologies by 33.3% during the 3rd quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after purchasing an additional 223,750 shares during the last quarter.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Barclays lifted their price target on shares of Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Wells Fargo & Company decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price on the stock. Piper Sandler started coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Finally, Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $160.93.

Agilent Technologies Trading Up 2.5%

NYSE:A opened at $127.49 on Friday. The company has a market cap of $36.01 billion, a P/E ratio of 25.60, a P/E/G ratio of 2.21 and a beta of 1.26. The stock’s fifty day moving average price is $121.28 and its two-hundred day moving average price is $126.92. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the business earned $1.31 earnings per share. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.